Blood News and Research

RSS

Children with severe, therapy-resistant asthma more likely to have poorer lung function: SARP

A subset of children with asthma suffers from severe, treatment-resistant disease associated with more illness and greater allergic hypersensitivity, according to the results of the National Heart, Blood, and Lung Institute's Severe Asthma Research Program, presented in a recently published article in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc..

10 Sep 2010

Method to predict risk of major coronary event may underestimate risk for millions of Americans: Study

A method that is widely used to predict the risk of a major coronary event may over- or underestimate risk for millions of Americans, according to a study directed by a researcher at the San Francisco VA Medical Center and the University of California, San Francisco.

10 Sep 2010

FDA approves pediatric use of Protopam Chloride

The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents). The drug is approved to be administered either by intravenous (IV) or intramuscular (IM) injections.

10 Sep 2010

NIH launches two research studies to examine ways to curtail childhood obesity epidemic

The National Institutes of Health is launching two major research efforts, totaling $72.5 million, to examine ways to curtail the nation's childhood obesity epidemic. One will study long-term approaches to prevent or treat childhood obesity, and the other will examine community efforts to reduce childhood obesity rates.

10 Sep 2010

AAOS releases clinical practice guideline for periprosthetic joint infection diagnosis

The American Academy of Orthopaedic Surgeons (AAOS) recently approved and released an evidence-based clinical practice guideline on the diagnosis of periprosthetic joint infections of the hip and knee. Clinical practice guidelines are one avenue the Academy uses to ensure that patients receive high quality care.

10 Sep 2010

UC Denver researcher awarded NIH grant to study PAH

A disease that has no cure in young children and adults is getting closer attention, thanks to a University of Colorado Denver Bioengineering assistant professor and a five year National Heart Lung and Blood Institute/National Institutes of Health grant. Kendall Hunter, PhD, will perform research to improve the diagnosis and prognosis of pulmonary arterial hypertension in children and adults with approximately $700,000 over a five-year period.

10 Sep 2010

Researchers find risk prediction model for VTE in cancer patients

For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology.

10 Sep 2010

Mayo Clinic opens newly expanded neurophysiology laboratory at Florida campus

Mayo Clinic unveiled a newly expanded, state-of-the-art neurophysiology laboratory on its Florida campus to provide additional services and care for more patients, many of whom are referred by community physicians for specialized diagnostic testing.

10 Sep 2010

Calif. regulators seek $9.9 billion fine from insurer; Few Iowans sign up for high risk pool; N.D. Court rejects ballot measure on drug store ownership

California regulators are seeking fines of up to $9.9 billion from a unit of health insurer UnitedHealth Group Inc, citing mismanaged medical claims, failure to pay doctors and other lapses.

10 Sep 2010

VAP Cholesterol Test can evaluate Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome, known as PCOS, is a silent and often mysterious disease that plays havoc with a woman's body and increases the risk of serious illness. There is no single test for diagnosing the illness, but a detailed cholesterol profile called the VAP Cholesterol Test, along with diet, exercise and the right medication, is changing how doctors approach PCOS and is dramatically altering patients' lives for the better.

10 Sep 2010

FDA approves Abreu BTT 700 System for temperature monitoring

Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.

10 Sep 2010

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £2.5 million through a rights issue to existing investors. The round was significantly oversubscribed and completed within four weeks.

9 Sep 2010

3M to acquire Arizant for $810M

3M announced today it has entered into a definitive agreement to acquire Arizant Inc. for a purchase price of $810 million in cash. Based in Eden Prairie, Minn., Arizant is a leading manufacturer of patient warming solutions designed to prevent hypothermia in surgical settings.

9 Sep 2010

Researchers discover first compound to activate enzyme telomerase in human body

Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.

9 Sep 2010

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.

9 Sep 2010

WHO forum to review developing country access to life-saving medical devices

More than 350 leading health experts from over 100 countries meet today at a World Health Organization (WHO) forum in Bangkok, Thailand to review new evidence and agree ways to improve developing country access to life-saving medical devices.

9 Sep 2010

APhA to highlight increasing role of pharmacists in improving health, well-being

In honor of Cholesterol Education Month, The American Pharmacists Association would like to highlight the increasing role of the pharmacist in communities nationwide. In many areas, pharmacists are able to offer cholesterol and blood pressure screenings, as well as other detection and prevention services to help a patient manage their healthcare and get the most out the medications they may be taking.

9 Sep 2010

Scientists develop new strategy for quicker detection of biomarkers that indicate disease

Scientists at the UK's National Physical Laboratory have developed a new strategy for quicker and more precise detection of biomarkers - proteins which indicate disease. The work could pave the way for new tools to detect early stages of Alzheimer's and cancer at the molecular level.

9 Sep 2010

IMF and CHPF join to promote awareness of myeloma in China

The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.

9 Sep 2010

Experts examine impact of two cardiac rescue strategies: chest compressions first vs. defibrillation first

Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.

9 Sep 2010

Blood News and Research

Children with severe, therapy-resistant asthma more likely to have poorer lung function: SARP

Method to predict risk of major coronary event may underestimate risk for millions of Americans: Study

FDA approves pediatric use of Protopam Chloride

NIH launches two research studies to examine ways to curtail childhood obesity epidemic

AAOS releases clinical practice guideline for periprosthetic joint infection diagnosis

UC Denver researcher awarded NIH grant to study PAH

Researchers find risk prediction model for VTE in cancer patients

Mayo Clinic opens newly expanded neurophysiology laboratory at Florida campus

Calif. regulators seek $9.9 billion fine from insurer; Few Iowans sign up for high risk pool; N.D. Court rejects ballot measure on drug store ownership

VAP Cholesterol Test can evaluate Polycystic Ovarian Syndrome

FDA approves Abreu BTT 700 System for temperature monitoring

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

3M to acquire Arizant for $810M

Researchers discover first compound to activate enzyme telomerase in human body

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

WHO forum to review developing country access to life-saving medical devices

APhA to highlight increasing role of pharmacists in improving health, well-being

Scientists develop new strategy for quicker detection of biomarkers that indicate disease

IMF and CHPF join to promote awareness of myeloma in China

Experts examine impact of two cardiac rescue strategies: chest compressions first vs. defibrillation first

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News